Aptabio Ranks High in Searches... Stock Price Up 5.1%

Aptabio has ranked among the top searched stocks on 4 days within the past month.

As of 11:30 AM on the 7th, Aptabio is trading at 76,200 KRW, up 5.1% from the previous day. This marks a 103.2% increase compared to December 11.

Over the past 5 days, individual investors have net purchased 205,636 shares, while foreign investors and institutions have net sold 76,892 shares and 116,421 shares, respectively.

On January 6, Aptabio became a market issue with a surge in price due to its "COVID-19 treatment drug FDA Phase 2 clinical trial application."

※Source: AI investment assistant AI Rasero

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.